An allogeneic bioengineered myocardial graft limits infarct size and improves cardiac function: pre-clinical study in the porcine myocardial infarction model
iPS derived from human urine of Duchenne patients generate functionally competent cardiomyogenic cells: an in vitro cell model for functional studies and drug testing in heart failure.
Speaker:
Associate Professor D. D'Amario (Novara, IT)